Biopharmaceutical company
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Based on 2 scored insights about Centessa Pharmaceuticals plc.
The 2 sources with the most insights about Centessa Pharmaceuticals plc on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Recently acquired by Eli Lilly for its promising Orexin pathway treatments.
Acquired by Eli Lilly; central to the high-potential 'lifestyle drug' market for sleep reduction.
Recently acquired by Eli Lilly for its promising Orexin pathway treatments.
Acquired by Eli Lilly; central to the high-potential 'lifestyle drug' market for sleep reduction.
Other assets that creators frequently mention in the same content as Centessa Pharmaceuticals plc.
The most active sources covering Centessa Pharmaceuticals plc (CNTA) on Kazuha are @peterdiamandis, PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about Centessa Pharmaceuticals plc (CNTA) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Centessa Pharmaceuticals plc (CNTA) most frequently also discuss BABA, IBM, LLY, RGTI, QBTS. See the "Discussed alongside" section above for full asset pages.